New work identifies a potential therapeutic target for clogged arteries and other health risks that stem from an excess of harmful fats in the bloodstream. The study opens the door for the design of more specific MTP inhibitors that could reduce circulating triglyceride levels without the risk of unpleasant and serious side effects in the intestines and liver.
Click here for original story, Newly discovered mutation could point to heart disease therapeutic target
Source: ScienceDaily